Bispecific dendritic-T cell engager potentiates anti-tumor immunity
Top Cited Papers
- 18 January 2024
- Vol. 187 (2) , 375-389.e18
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Massively Parallel Single-Cell RNA-Seq for Marker-Free Decomposition of Tissues into Cell TypesScience, 2014
- Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T CellsCancer Research, 2014
- Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic CellsImmunity, 2012
- Decisions About Dendritic Cells: Past, Present, and FutureAnnual Review of Immunology, 2012
- Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodiesProceedings of the National Academy of Sciences, 2011
- Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cellsJournal of Experimental Medicine, 2010
- Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell ImmunityScience, 2008
- A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12–independent but CD70-dependent mechanism in vivoJournal of Experimental Medicine, 2007
- A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administrationNature Methods, 2005
- An efficient route to human bispecific IgGNature Biotechnology, 1998